Add Axios as your preferred source to
see more of our stories on Google.
Illustration: Shoshana Gordon/Axios
Walmart is making a play to own what it calls the "last mile" of the GLP-1 boom, telling Axios exclusively it's launching a platform that goes beyond prescriptions to combine virtual care and nutrition.
Why it matters: Weight-loss treatments like Ozempic, Wegovy and Zepbound are exploding, but the real friction is everything around them. The retail giant is betting it can simplify that fragmented system.
